Hong Ji

566 total citations
31 papers, 441 citations indexed

About

Hong Ji is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hong Ji has authored 31 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 11 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hong Ji's work include Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (4 papers) and MicroRNA in disease regulation (3 papers). Hong Ji is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (4 papers) and MicroRNA in disease regulation (3 papers). Hong Ji collaborates with scholars based in China, Taiwan and South Korea. Hong Ji's co-authors include Chia Wen Tsai, Wen Shin Chang, Lirong Zhang, Lei Wang, Xin Guo, Yiming Ma, Ying Xiong, Zhen Liu, Da Tian Bau and Cuizhi Geng and has published in prestigious journals such as Gastroenterology, Biomedicine & Pharmacotherapy and Frontiers in Oncology.

In The Last Decade

Hong Ji

30 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Ji China 13 253 179 94 44 43 31 441
Nader Hussein Lebanon 14 432 1.7× 223 1.2× 102 1.1× 29 0.7× 60 1.4× 24 599
Jinglue Song China 10 243 1.0× 95 0.5× 97 1.0× 30 0.7× 55 1.3× 16 411
Weifang Yu China 14 216 0.9× 110 0.6× 80 0.9× 32 0.7× 47 1.1× 30 427
Javier Cotignola Argentina 15 331 1.3× 137 0.8× 128 1.4× 47 1.1× 83 1.9× 32 568
Tamara Djurić Serbia 13 134 0.5× 122 0.7× 85 0.9× 33 0.8× 98 2.3× 52 409
Tianbo Jin China 15 301 1.2× 137 0.8× 77 0.8× 26 0.6× 76 1.8× 48 522
Pang-Kuo Lo United States 10 476 1.9× 165 0.9× 106 1.1× 27 0.6× 21 0.5× 11 601
Dan‐Ming Wei China 11 271 1.1× 182 1.0× 59 0.6× 23 0.5× 36 0.8× 26 422

Countries citing papers authored by Hong Ji

Since Specialization
Citations

This map shows the geographic impact of Hong Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Ji more than expected).

Fields of papers citing papers by Hong Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Ji. The network helps show where Hong Ji may publish in the future.

Co-authorship network of co-authors of Hong Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Ji. A scholar is included among the top collaborators of Hong Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Ji. Hong Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Hong, et al.. (2021). Detection of Early Vascular Atherosclerosis in Type 2 Diabetes Mellitus Using Ultrasound Radiofrequency-Data Technique. Journal of Stroke and Cerebrovascular Diseases. 30(6). 105751–105751.
2.
Sun, Yu, et al.. (2020). Clinical efficacy analysis of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in primary liver cancer and recurrent liver cancer.. PubMed. 24(4). 1402–1407. 15 indexed citations
3.
Ji, Hong, et al.. (2020). Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients. Breast Cancer. 28(2). 513–526. 2 indexed citations
4.
Chu, Wei, Li Zhang, Baoguang Hu, et al.. (2020). Dysregulation of Long Non-coding RNAs and mRNAs in Plasma of Clear Cell Renal Cell Carcinoma Patients Using Microarray and Bioinformatic Analysis. Frontiers in Oncology. 10. 559730–559730. 12 indexed citations
5.
Kong, Yan, Dong Qian, Hong Ji, et al.. (2019). The Effect of the Leptin and Leptin Receptor Expression on the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer. Medical Science Monitor. 25. 3005–3013. 6 indexed citations
6.
Li, Bo, et al.. (2019). MicroRNA‑466 inhibits cancer cell migration and invasion in hepatocellular carcinoma by indirectly mediating the downregulation of ROCK2. Experimental and Therapeutic Medicine. 18(2). 1493–1499. 7 indexed citations
7.
Ji, Hong, et al.. (2018). miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer. Pathology - Research and Practice. 215(4). 697–704. 42 indexed citations
8.
Guo, Xin, Lirong Zhang, Yiming Ma, et al.. (2018). Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway. Biomedicine & Pharmacotherapy. 107. 484–494. 85 indexed citations
9.
Tsai, Chia Wen, Wen Shin Chang, Hong Ji, et al.. (2017). The Contribution of Matrix Metalloproteinase-1 Genotype to Oral Cancer Susceptibility in Taiwan.. PubMed. 30(4). 439–44. 21 indexed citations
10.
11.
Chen, Su, Hong Ji, Te Chun Hsia, et al.. (2016). Matrix Metalloproteinase-1 Genetic Polymorphism in Breast Cancer in Taiwanese.. PubMed. 36(7). 3341–5. 11 indexed citations
12.
Yan, Li, et al.. (2016). Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma. Cellular Physiology and Biochemistry. 38(3). 1075–1084. 31 indexed citations
14.
Chang, Wen Shin, et al.. (2015). Contribution of Interleukin-4 Genotypes to Lung Cancer Risk in Taiwan.. PubMed. 35(11). 6297–301. 11 indexed citations
15.
Ji, Hong. (2014). The Expression and Clinical Significance of miR-450a-5p in Serous Ovarian Cancer. Xiandai shengwu yixue jinzhan. 1 indexed citations
16.
Gao, Qing, et al.. (2014). Cardiomyocyte-like cells differentiation from non β-catenin expression mesenchymal stem cells. Cytotechnology. 66(4). 575–584. 2 indexed citations
17.
Kang, Seung‐Gul, Bun-Hee Lee, Jun‐Seok Lee, et al.. (2014). DRD3 Gene rs6280 Polymorphism May Be Associated with Alcohol Dependence Overall and with Lesch Type I Alcohol Dependence in Koreans. Neuropsychobiology. 69(3). 140–146. 16 indexed citations
18.
Zhang, Bing, et al.. (2013). Lack of association of microvessel density with prognosis of renal cell carcinoma: evidence from meta-analysis. Tumor Biology. 35(3). 2769–2776. 6 indexed citations
19.
Wan, Xiang‐Bo, Xinjuan Fan, Ming‐Yuan Chen, et al.. (2009). Inhibition of Aurora-A results in increased cell death in 3-dimensional culture microenvironment, reduced migration and is associated with enhanced radiosensitivity in human nasopharyngeal carcinoma. Cancer Biology & Therapy. 8(15). 1500–1506. 8 indexed citations
20.
Ji, Hong, et al.. (1969). Clinical pathologies of breast cancer in the elderly and youths and their prognosis. Pakistan Journal of Medical Sciences. 30(3). 535–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026